Bucher J R, Roberts R J
Pediatr Pharmacol (New York). 1982;2(1):1-9.
The efficacy of alpha-tocopherol treatment to influence the pattern or extent of lung injury resulting during exposure of newborn rats to hyperoxia was assessed following six-day exposures to FIO2 0.21, 0.4, and greater than 0.95. Alpha-Tocopherol treatment was found incapable of preventing the developmental arrest of the lung that occurs during hyperoxic exposure, shown by assessments of wet lung weights, lung DNA, lung volumes, and the progress of secondary septal and capillary development. However alpha-tocopherol treatment was found effective in preventing the hyperoxic-induced lessening of lung compliance and in preventing the deterioration of gas exchange capacity in the lung of the hyperoxic-exposed newborn rat. These findings suggest alpha-tocopherol treatment may not be capable of preventing major alterations in lung morphology in infants with chronic lung disease may be lessened by preserving gas exchange capabilities.
在新生大鼠暴露于不同氧浓度环境六天后,评估了α-生育酚治疗对影响新生大鼠暴露于高氧环境时肺损伤模式或程度的效果。所设置的氧浓度分别为FIO2 0.21、0.4和大于0.95。通过对湿肺重量、肺DNA、肺容积以及次级隔膜和毛细血管发育进程的评估发现,α-生育酚治疗无法预防高氧暴露期间发生的肺发育停滞。然而,发现α-生育酚治疗可有效预防高氧诱导的肺顺应性降低,并预防高氧暴露新生大鼠肺气体交换能力的恶化。这些发现表明,α-生育酚治疗可能无法预防慢性肺病婴儿的肺形态学重大改变,但通过保留气体交换能力,这种改变可能会减轻。